| Moderna CMO Talks COVID-19 Vaccine at the Xcelerate Keynote Series | Editors | 09/16/20 | Boston |
| Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More | Frank Vinluan | 09/11/20 | National |
| Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More | Frank Vinluan | 09/04/20 | National |
| CureVac’s IPO Hauls In $213M as Key mRNA COVID-19 Vaccine Test Nears | Frank Vinluan | 08/14/20 | Europe |
| Moderna, Pfizer Protocols May Make COVID Vaccines Hard to Compare | Sarah Karlin-Smith | 08/07/20 | National |
| GSK Pays CureVac $328M in mRNA Vaccines Pact—Excluding COVID-19 | Frank Vinluan | 07/20/20 | Europe |
| Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More | Frank Vinluan | 07/17/20 | National |
| Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients | Sarah Karlin-Smith | 07/02/20 | National |
| BioNTech’s mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity | Frank Vinluan | 07/01/20 | Europe |
| FDA Reverses Authorization for Use of Antimalarials to Treat COVID-19 | Sarah de Crescenzo | 06/15/20 | National |
| Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More | Sarah de Crescenzo | 06/12/20 | National |
| Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More | Frank Vinluan | 06/05/20 | National |
| FDA Welcomes Variety of Phase 2/3 Trial Designs for COVID-19 Therapies | Bridget Silverman | 05/28/20 | National |
| Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq | Frank Vinluan | 05/22/20 | National |
| Early COVID-19 Vaccine Data Sets Up Moderna for Next Stages of Testing | Frank Vinluan | 05/18/20 | Boston |
| Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More | Sarah de Crescenzo | 05/01/20 | National |
| Arcturus Poised to Move Liver Drug, COVID-19 Vaccine Into Clinic | Sarah de Crescenzo | 04/14/20 | San Diego |
| Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More | Frank Vinluan | 04/10/20 | National |
| Bio Roundup: Coronavirus Diagnostics, Therapeutics, Vaccines & More | Sarah de Crescenzo | 03/20/20 | National |
| AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening | Sarah de Crescenzo | 03/17/20 | National |
| Gilead, Moderna Candidates Ramp Up Coronavirus Drug, Vaccine Testing | Sarah de Crescenzo | 02/27/20 | National |
| Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More | Sarah de Crescenzo | 11/15/19 | National |
| Bio Roundup: Pelosi’s Reveal, Alder’s Deal, Biogen’s Fails & More | Alex Lash | 09/20/19 | National |
| ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More | Alex Lash | 06/05/19 | National |
| Bio Roundup: Gottlieb Exits, Bristol Defends, Biogen Buys & More | Alex Lash | 03/08/19 | National |
| WI Watchlist: FluGen, Propeller Health, Gener8tor, EnSync | Jeff Bauter Engel | 02/15/19 | Wisconsin |
| WI Watchlist: Gener8tor, FluGen, Sift Healthcare, Titan Spine | Jeff Bauter Engel | 11/19/18 | Wisconsin |
| Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More | Alex Lash | 10/12/18 | National |
| Bio Roundup: EpiPen Shortage, Bluebird’s Bet, Biotech IPOs & More | Frank Vinluan | 08/24/18 | National |
| No Self-Editing: Biohacker Josiah Zayner Can’t Stop Living Out Loud | Alex Lash | 03/13/18 | San Francisco |
